Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on DWP16001 Pharmacokinetics in Healthy Volunteers
NCT05797922Phase 1Unknown
- Sponsor
- Daewoong Pharmaceutical
- Start
- Mar 2023
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of enavogliflozin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Daewoong Pharmaceutical. Primary endpoints: Area Under the Concentration-time Curve from time 0 to time t and Maximum Plasma Concentration. Status: unknown.
02
Drugs
enavogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05797922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05797922.